Selected article for: "local immunity and lymphoid tissue"
Author: Zaman, Mehfuz; Chandrudu, Saranya; Toth, Istvan
Title: Strategies for intranasal delivery of vaccines
  • Cord-id: kb2wrxio
  • Document date: 2012_7_12
    • ID: kb2wrxio
    Snippet: The vast majority of human pathogens colonize and invade at the mucosal surfaces. Preventing infection at these sites via mucosally active vaccines is a promising and rational approach for vaccine development. However, it is only recently that the stimulation of local immunity at the mucosal surfaces has become a primary objective in addition to inducing systemic immunity. This review describes vaccine formulations designed for mucosal delivery to the nasal-associated lymphoid tissue, via intran
    Document: The vast majority of human pathogens colonize and invade at the mucosal surfaces. Preventing infection at these sites via mucosally active vaccines is a promising and rational approach for vaccine development. However, it is only recently that the stimulation of local immunity at the mucosal surfaces has become a primary objective in addition to inducing systemic immunity. This review describes vaccine formulations designed for mucosal delivery to the nasal-associated lymphoid tissue, via intranasal administration. The association of antigens with mucosal adjuvants and delivery systems is emphasised.

    Search related documents:
    Co phrase search for related documents
    • active component and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • activity neutralize and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • acute sars cov respiratory syndrome coronavirus and additional protection: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and adhesion enhance: 1
    • acute sars cov respiratory syndrome coronavirus and adjuvant delivery: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and adjuvant effect: 1, 2, 3, 4
    • acute sars cov respiratory syndrome coronavirus and adjuvant presence: 1, 2
    • additional adjuvant and adjuvant effect: 1, 2, 3, 4